Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials

Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection

(2009) Antonio Ascione et al.   GASTROENTEROLOGY

Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C

(2009) Maria Grazia Rumi et al.   GASTROENTEROLOGY

Effect of hepatitis C virus and its treatment on survival

(2009) Adeel A. Butt et al.   HEPATOLOGY

Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study

(2009) Hirofumi Uto et al.   HEPATOLOGY

Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use

(2009) S. Swaroop Vedula et al.   NEW ENGLAND JOURNAL OF MEDICINE

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized trial comparing pegylated interferon α-2b versus pegylated interferon α-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

(2008) Montserrat Laguno et al.   HEPATOLOGY

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

(2008) Kristian Thorlund et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses

(2008) Jesper Brok et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses

(2008) Jesper Brok et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

840 EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2a OR -2b PLUS RIBAVIRIN IN THE ROUTINE DAILY TREATMENT OF CHRONIC HEPATITIS C PATIENTS IN GERMANY: THE PRACTICE STUDY

(2008) T. Witthoeft et al.   JOURNAL OF HEPATOLOGY

Peg-Interferon Alpha-2a versus Peg-Interferon Alpha-2b in Nonresponders with HCV Active Chronic Hepatitis: A Pilot Study

(2008) Gaetano Scotto et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis

(2008) Sripal Bangalore et al.   LANCET

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

(2008) Erick H. Turner et al.   NEW ENGLAND JOURNAL OF MEDICINE

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal

Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis

(2008) Kirby Lee et al.   PLOS MEDICINE